DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/966f32/chronic_myelocytic) has announced the addition of GlobalData's new report "Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, H2, 2011" to their offering.
GlobalData's clinical trial report, Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, H2, 2011" provides data on the Chronic Myelocytic Leukemia (CML) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Myelocytic Leukemia (CML). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Myelocytic Leukemia (CML). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Key Topics Covered:
- Introduction
- Chronic Myelocytic Leukemia (CML)
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Countries Contributing to Clinical Trials in Middle East and Africa
- Top Five Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by BRIC Nations
- Clinical Trials by G7 Nations
- Clinical Trials in G7 Nations by Trial Status
- Clinical Trials by E7 Nations
- Clinical Trials in E7 Nations by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Chronic Myelocytic Leukemia (CML)
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Top Companies Participating in Chronic Myelocytic Leukemia (CML) Therapeutics Clinical Trials
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Key Clinical Trials
- Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
For more information visit http://www.researchandmarkets.com/research/966f32/chronic_myelocytic